Aayush Agrawal, a promoter of Ajanta Pharma Limited, has reported recent changes to his share encumbrance status. On May 12, 2026, the promoter completed both a pledge creation and a pledge release of 2,86,213 shares each. The transaction was conducted with Julius Baer Capital (India) Pvt Ltd. These movements were executed to secure a new loan and settle a previous debt, respectively, as part of routine financial management.
Summary of Share Pledge Activity
As of May 13, 2026, Ajanta Pharma Limited promoter Aayush Agrawal (in his capacity as trustee for the Aayush Agrawal Trust) has disclosed balanced changes to his pledged shareholding. The promoter successfully created a new pledge on 2,86,213 shares and simultaneously released an equivalent volume of 2,86,213 shares.
Transaction Details
Both the creation and release of the encumbrance occurred on May 12, 2026. The shares were held in favor of Julius Baer Capital (India) Pvt Ltd. According to the disclosure, the purpose of creating the new pledge was to facilitate a new loan, while the release of the previous pledge was attributed to the repayment of an existing loan.
Impact on Shareholding
Following these transactions, the post-event encumbered holding by the Aayush Agrawal Trust stands at 87,81,662 shares, representing 7.03% of the total share capital of Ajanta Pharma Limited. This disclosure ensures transparency regarding promoter-level financial activities and their interest in the company’s equity structure.
Source: BSE
